Skip to content
naulon
Not checkedNot checked for notices yet.

Serratiopeptidase: Insights into the therapeutic applications

Swati B. Jadhav, Neha Shah, Ankit Rathi and 2 more

Biotechnology Reports · 2020

doi:10.1016/j.btre.2020.e00544 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Therapeutic applications of enzymes have been widely accepted in clinical practices for decades. Proteolytic enzymes in particular, have been used for the treatment of diseases and disorders. Serratiopeptidase is a proteolytic enzyme having immense applications in therapeutic areas which have been validated by several in vitro, in vivo, and clinical studies as well as through anecdotal evidences. These applications are attributable to its versatile properties including anti-inflammatory, anti-biofilm, analgesic, anti-edemic, and fibrinolytic effects. The significant impact of serratiopeptidase reported needs to be backed by more scientific data. This review encompasses the details of therapeutic applications of serratiopeptidase based on available in vitro, in vivo, and clinical studies. We found some strong evidences regarding the efficacy of serratiopeptidase. However data on safety, tolerability, and its mechanism of action need detailing. This review aims to further explore the available literature on serratiopeptidase as well as provide scientific details for existing applications.

Abstract licence: CC BY-NC

References76

    40 more references, whose wording the paper’s licence keeps private.

    All 76 references

    Cited by papers we hold1

    Reads

    Read by people on this page

    None yet.

    Checked or read by AI through naulon

    None yet.

    A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

    Are you an author?

    Is this your paper?

    Claim it to add your note and be paid when agents cite it. Free.